← All Sponsors
SPONSOR

Michael K. Gibson

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Metastatic Oropharyngeal CarcinomaRecurrent Oropharyngeal Carcinoma
NCT05799144 Phase 2
Recruiting

pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer

Metastatic Oropharyngeal Carcinoma
United States View Trial →